Shares of Extendicare Inc. (TSE:EXE – Get Free Report) have been given an average rating of “Buy” by the seven brokerages that are covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued a report on the stock in the last year is C$37.00.
Several equities analysts have recently weighed in on EXE shares. Desjardins decreased their target price on Extendicare from C$40.00 to C$39.00 and set a “buy” rating on the stock in a research report on Monday, August 10th. Royal Bank Of Canada boosted their price target on Extendicare from C$38.00 to C$39.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Finally, Canaccord Genuity Group increased their price objective on Extendicare from C$37.00 to C$44.00 and gave the company a “buy” rating in a research note on Monday, August 10th.
Get Our Latest Stock Analysis on Extendicare
Extendicare Trading Down 0.0%
Extendicare (TSE:EXE – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported C$0.38 earnings per share (EPS) for the quarter. Extendicare had a return on equity of 36.33% and a net margin of 6.13%. The company had revenue of C$611.04 million for the quarter. On average, sell-side analysts predict that Extendicare will post 0.61 EPS for the current fiscal year.
Extendicare Announces Dividend
The company also recently disclosed a monthly dividend, which was paid on Monday, August 17th. Shareholders of record on Monday, August 17th were issued a $0.0441 dividend. The ex-dividend date was Friday, July 31st. This represents a $0.53 dividend on an annualized basis and a yield of 2.0%. Extendicare’s dividend payout ratio (DPR) is presently 39.23%.
About Extendicare
Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.
Further Reading
- Five stocks we like better than Extendicare
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
